Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis

NCT03449758 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: SARILUMAB
DRUG: Azathioprine
DRUG: Chloroquine
DRUG: Hydroxychloroquine
DRUG: Leflunomide
DRUG: Methotrexate
DRUG: Sulfasalazine

Sponsor

Sanofi

Collaborators

[object Object]